摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(5-碘-2-吡啶基)胡椒嗪-1-羧酸叔丁酯 | 497915-42-1

中文名称
4-(5-碘-2-吡啶基)胡椒嗪-1-羧酸叔丁酯
中文别名
1-BOC-4-(5-碘-2-吡啶基)哌嗪
英文名称
4-(5-iodopyridin-2-yl)piperazine-1-carboxylic acid tert-butyl ester
英文别名
tert-butyl 4-(5-iodopyridin-2-yl)piperazine-1-carboxylate;tert-butyl 4-(5-iodo-2-pyridyl)piperazine-1-carboxylate
4-(5-碘-2-吡啶基)胡椒嗪-1-羧酸叔丁酯化学式
CAS
497915-42-1
化学式
C14H20IN3O2
mdl
MFCD07781193
分子量
389.236
InChiKey
RJHWOWJRQNENIC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    102 °C
  • 沸点:
    457.5±45.0 °C(Predicted)
  • 密度:
    1.524±0.06 g/cm3(Predicted)
  • 稳定性/保质期:

    按规定使用和贮存的情况下,这些物质不会分解,并且能够避免与氧化物接触。

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.571
  • 拓扑面积:
    45.7
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 危险品标志:
    Xi
  • 海关编码:
    2933990090
  • 储存条件:
    请将药品存放在密闭、阴凉、干燥的地方。

SDS

SDS:b47f65bfa2b6d57e96dcb3ed43c1514f
查看
Material Safety Data Sheet

Section 1. Identification of the substance
1-Boc-4-(5-iodopyridin-2-yl)piperazine
Product Name:
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

Section 3. Composition/information on ingredients.
1-Boc-4-(5-iodopyridin-2-yl)piperazine
Ingredient name:
CAS number: 497915-42-1

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C14H20IN3O2
Molecular weight: 389.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen Iodide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Correction to “Nickel-Catalyzed Asymmetric Reductive Cross-Coupling To Access 1,1-Diarylalkanes”
    作者:Kelsey E. Poremba、Nathaniel T. Kadunce、Naoyuki Suzuki、Alan H. Cherney、Sarah E. Reisman
    DOI:10.1021/jacs.8b05247
    日期:2018.6.20
    Pages 5684 and 5685, Table of
    第 5684 页和第 5685 页,表
  • NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS
    申请人:BARONI Marco
    公开号:US20120245149A1
    公开(公告)日:2012-09-27
    The disclosure relates to (heterocycle-fused piperidine)-(piperazinyl)-1-alkanone derivatives and (heterocycle-fused pyrrolidine)-(piperazinyI)-1-alkanone derivatives of formula (I): wherein A, W, R2 and n are as defined in the disclosure, to the method of preparation thereof and the therapeutic use thereof.
    该公开涉及到式(I)的(杂环融合哌啶)-(哌嗪基)-1-烷酮衍生物和(杂环融合吡咯啉)-(哌嗪基)-1-烷酮衍生物: 其中A、W、R2和n如公开所定义,以及其制备方法和治疗用途。
  • ONE POT SYNTHESIS OF 18F LABELEDTRIFLUOROMETHYLATED COMPOUNDS WITH DIFLUORO(IODO)METHANE
    申请人:University of Oslo
    公开号:US20150239796A1
    公开(公告)日:2015-08-27
    The present invention relates to compositions and methods for the synthesis of 18 F labeled compounds. In particular, the present invention relates to a copper (I) mediated one pot method for 18 F-trifluoromethylation of aromatic- or heteroaromatic halides with difluoro(iodo)methane (e.g., for use at PET imaging agents).
    本发明涉及用于合成18F标记化合物的组合物和方法。具体而言,本发明涉及一种铜(I)介导的一锅法,用于将芳香或杂环卤代物与二氟(碘)甲烷进行18F-三氟甲基化(例如,用于PET成像剂)。
  • [EN] BENZENE OR THIOPHENE DERIVATIVE AND USE THEREOF AS VAP-1 INHIBITOR<br/>[FR] DÉRIVÉ DE BENZÈNE OU DE THIOPHÈNE ET SON UTILISATION EN TANT QU'INHIBITEUR DE LA VAP-1
    申请人:R TECH UENO LTD
    公开号:WO2009145360A1
    公开(公告)日:2009-12-03
    The present invention provides a novel benzene derivative or thiophene derivative useful as a VAP-1 inhibitor, or a medicament for the prophylaxis or treatment of a VAP-1 associated disease and the like, namely, a compound represented by the formula (I): wherein each symbol is as defined in the present specification, or a pharmaceutically acceptable salt thereof.
    本发明提供了一种新颖的苯衍生物或噻吩衍生物,可用作VAP-1抑制剂,或用作预防或治疗与VAP-1相关的疾病等的药物,即由以下式(I)表示的化合物:其中每个符号如本说明书中所定义,或其药学上可接受的盐。
  • Nickel-Catalyzed Asymmetric Reductive Cross-Coupling To Access 1,1-Diarylalkanes
    作者:Kelsey E. Poremba、Nathaniel T. Kadunce、Naoyuki Suzuki、Alan H. Cherney、Sarah E. Reisman
    DOI:10.1021/jacs.7b01705
    日期:2017.4.26
    reductive cross-coupling of (hetero)aryl iodides and benzylic chlorides has been developed to prepare enantioenriched 1,1-diarylalkanes. As part of these studies, a new chiral bioxazoline ligand, 4-heptyl-BiOX (L1), was developed in order to obtain products in synthetically useful yield and enantioselectivity. The reaction tolerates a variety of heterocyclic coupling partners, including pyridines, pyrimidines
    已经开发了(杂)芳基碘化物和苄基氯化物的不对称 Ni 催化还原交叉偶联,以制备对映体富集的 1,1-二芳基烷烃。作为这些研究的一部分,开发了一种新的手性生物恶唑啉配体 4-庚基-BiOX (L1),以便以合成有用的产率和对映选择性获得产品。该反应耐受多种杂环偶联物,包括吡啶、嘧啶、吲哚和哌啶。
查看更多